Skip to content

Trial Summary

Electronic CRPC Australian Database (ePAD): Analyzing treatment patterns and outcomes from real-world patients with castrate-resistant prostate cancer



ACTRN/NCT /ethics:

Scientific title:

Sponsor / Cooperative group:

Melb Health

Trial & Patient Characteristics

Cancer TypeProstate
Trial TypeEarly detection, diagnosis, prognosis
Age Range18 years and older
Tumour Stream -
Cancer StageLocally Recurrent or Locally Advanced
Anticipated Start Date-
Anticipated End Date-

Participating Hospitals

HospitalAshford Cancer Centre Research
Clinical Trial CoordinatorSue Yeend
Phone08 8292 2240
Principal InvestigatorDr Francis Parnis
Recruitment StatusRecruiting